Legislation

Search OpenLegislation Statutes
This entry was published on 2021-04-02
The selection dates indicate all change milestones for the entire volume, not just the location being viewed. Specifying a milestone date will retrieve the most recent version of the location before that date.
SECTION 3306
Schedules of controlled substances
Public Health (PBH) CHAPTER 45, ARTICLE 33, TITLE 1
§ 3306. Schedules of controlled substances. There are hereby
established five schedules of controlled substances, to be known as
schedules I, II, III, IV and V respectively. Such schedules shall
consist of the following substances by whatever name or chemical
designation known:

Schedule I. (a) Schedule I shall consist of the drugs and other
substances, by whatever official name, common or usual name, chemical
name, or brand name designated, listed in this section.

(b) Opiates. Unless specifically excepted or unless listed in another
schedule, any of the following opiates, including their isomers, esters,
ethers, salts, and salts of isomers, esters, and ethers, whenever the
existence of such isomers, esters, ethers and salts is possible within
the specific chemical designation (for purposes of 3-methylfentanyl
only, the term isomer includes the optical and geometric isomers):

(1) Acetyl-alpha-methylfentanyl (N-{1-(-methyl-2-phenethyl)
-4-piperidinyl} -N-phenylacetamide.

(2) Acetylmethadol.

(3) Allylprodine.

(4) Alphacetylmethadol (except levo- alphacetylmethadol also known as
levo-alpha-acetylmethadol, levomethadylacetate or LAAM).

(5) Alphameprodine.

(6) Alphamethadol.

(7) Alpha-methylfentanyl (N-{1-(alpha-methyl-beta-phenyl)
ethyl-4-piperidyl} propionanilide; 1-(1-methyl-2-phenylethyl)
-4-(N-propanilido) piperidine).

(8) Alpha-methylthiofentanyl (N-{1-methyl-2)2-thienyl)
ethyl-4-piperidinyl} -N-phenylpropanamide).

(9) Beta-hydroxyfentanyl
(N-{1-2 (2-hydroxy-2-phenethyl)- 4-piperidinyl} -N-phenylpropanamide).

(10) Beta-hydroxy-3-methylfentanyl (other name: N-{1-
(2-hydroxy-2-phenethyl) -3-methyl -4-piperidinyl} -N-phenylpropanamide.

(11) Benzethidine.

(12) Betacetylmethadol.

(13) Betameprodine.

(14) Betamethadol.

(15) Betaprodine.

(16) Clonitazene.

(17) Dextromoramide.

(18) Diampromide.

(19) Diethylthiambutene.

(20) Difenoxin.

(21) Dimenoxadol.

(22) Dimepheptanol.

(23) Dimethylthiambutene.

(24) Dioxaphetyl butyrate.

(25) Dipipanone.

(26) Ethylmethylthiambutene.

(27) Etonitazene.

(28) Etoxeridine.

(29) Furethidine.

(30) Hydroxypethidine.

(31) Ketobemidone.

(32) Levomoramide.

(33) Levophenacylmorphan.

(34) 3-Methylfentanyl (N-{3-methy1-1- (2- phenylethyl -4-piperidyl}
-N-phenylpropanamide).

(35) 3-Methylthiofentanyl (N-{3-methyl-1- (2-thienyl)ethyl
-4-piperidinyl} -N-phenylpropanamide).

(36) Morpheridine.

(37) MPPP (1-methyl -4-phenyl -4-propionoxypiperidine).

(38) Noracymethadol.

(39) Norlevorphanol.

(40) Normethadone.

(41) Norpipanone.

(42) Para-fluorofentanyl (N- (4-fluorophenyl) -N-{1- (2-phenethyl)
-4-piperidinyl} -propanamide.

(43) PEPAP (1- (-2-phenethyl) -4-phenyl -4-acetoxypiperidine.

(44) Phenadoxone.

(45) Phenampromide.

(46) Phenomorphan.

(47) Phenoperidine.

(48) Piritramide.

(49) Proheptazine.

(50) Properidine.

(51) Propiram.

(52) Racemoramide.

(53) Thiofentanyl (N-phenyl-N-{1- (2-thienyl) ethyl -4- piperidinyl}
-propanamide.

(54) Tilidine.

(55) Trimeperidine.

(56) 3,4-dichloro-N-{(1-dimethylamino)cyclohexylmethyl}benzamide.
Some trade or other names: AH-7921.

(57) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide. Some trade or
other names: Acetyl Fentanyl.

(58) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide. Other name:
Butyryl Fentanyl.

(59) N-{1-{2-hydroxy-2-(thiophen-2-yl)ethyl}piperidin-4-yl}-N-phenylp-
ropionamide. Other name: Beta-Hydroxythiofentanyl.

(60) N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide. Other
name: Furanyl Fentanyl.

(61) 3,4-Dichloro-N-{2-(dimethylamino) cyclohexyl}-N-methylbenzamide.
Other name: U-47700.

(62) N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide. Other names:
Acryl Fentanyl or Acryloylfentanyl.

(63) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide.
Other names: 4-fluoroisobutyryl fentanyl, para-fluoroisobutyryl
fentanyl.

(64) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide.
Other names: ortho-fluorofentanyl or 2-fluorofentanyl.

(65) N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carbox-
amide. Other name: tetrahydrofuranyl fentanyl.

(66) 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide. Other
name: methoxyacetyl fentanyl.

(67) N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide.
Other name: cyclopropyl fentanyl.

(68) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide. Other
name: para-fluorobutyrylfentanyl.

(69) N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetam-
ide. Other name: Ocfentanil.

(70) 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine. Other name: MT-45.

(c) Opium derivatives. Unless specifically excepted or unless listed
in another schedule, any of the following opium derivatives, its salts,
isomers, and salts of isomers whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific chemical
designation:

(1) Acetorphine.

(2) Acetyldihydrocodeine.

(3) Benzylmorphine.

(4) Codeine methylbromide.

(5) Codeine-N-oxide.

(6) Cyprenorphine.

(7) Desomorphine.

(8) Dihydromorphine.

(9) Drotebanol.

(10) Etorphine (except hydrochloride salt).

(11) Heroin.

(12) Hydromorphinol.

(13) Methyldesorphine.

(14) Methyldihydromorphine.

(15) Morphine methylbromide.

(16) Morphine methylsulfonate.

(17) Morphine-N-oxide.

(18) Myrophine.

(19) Nicocodeine.

(20) Nicomorphine.

(21) Normorphine.

(22) Pholcodine.

(23) Thebacon.

(d) Hallucinogenic substances. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture, or
preparation, which contains any quantity of the following hallucinogenic
substances, or which contains any of its salts, isomers, and salts of
isomers whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation (for
purposes of this paragraph only, the term "isomer" includes the optical,
position and geometric isomers):
(EXPLANATION--Within the following chemical designations, character

symbol substitutions were made from the original text: "@" = Greek

alpha, "&" = Greek beta, "'" = prime mark and "/\" = triangle.)

(1) 4-bromo-2, 5-dimethoxy-amphetamine Some trade or other names:
4-bromo-2, 5-dimethoxy-@-methylphenethylamine; 4-bromo-2, 5-DMA.

(2) 2, 5-dimethoxyamphetamine Some trade or other names:
2, 5-dimethoxy-@-methylphenethylamine; 2, 5-DMA.

(3) 4-methoxyamphetamine Some trade or other names:
4-methoxy-@-methylphenethylamine; paramethoxyamphetamine, PMA.

(4) 5-methoxy-3, 4-methylenedioxy - amphetamine.

(5) 4-methyl-2, 5-dimethoxy-amphetamine Some trade and other names:
4-methyl-2, 5-dimethoxy-@-methylphenethylamine; "DOM"; and "STP".

(6) 3, 4-methylenedioxy amphetamine.

(7) 3, 4, 5-trimethoxy amphetamine.

(8) Bufotenine Some trade and other names: 3-(&-dimethylaminoethyl)-5
hydroxindole; 3-(2-dimethylaminoethyl)- 5-indolol;
N, N-dimethylserotonin; -5-hydroxy-N, N-dimethyltryptamine; mappine.

(9) Diethyltryptamine Some trade and other names:
N, N-diethyltryptamine; DET.

(10) Dimethyltryptamine Some trade or other names: DMT.

(11) Ibogane Some trade and other names: 7-ethyl-6, 6&, 7, 8, 9, 10,
12, 13-octahydro-2-methoxy-6, 9-methano-5h-pyrido {1',2':1,2} azepino
{5,4-b} indole: tabernanthe iboga.

(12) Lysergic acid diethylamide.

(13) Mescaline.

(14) Parahexyl. Some trade or other names: 3-Hexyl-1-hydroxy-
7,8,9,10-tetra hydro-6,6,9-trimethyl-6H-dibenfo{b,d} pyran.

(15) Peyote. Meaning all parts of the plant presently classified
botanically as Lophophora williamsii Lemaire, whether growing or not,
the seeds thereof, any extract from any part of such plant, and every
compound, manufacture, salts, derivative, mixture, or preparation of
such plant, its seeds or extracts.

(16) N-ethyl-3-piperidyl benzilate.

(17) N-methyl-3-piperidyl benzilate.

(18) Psilocybin.

(19) Psilocyn.

(20) Tetrahydrocannabinols. Synthetic tetrahydrocannabinols not
derived from the cannabis plant that are equivalents of the substances
contained in the plant, or in the resinous extractives of cannabis, sp.
and/or synthetic substances, derivatives, and their isomers with similar
chemical structure and pharmacological activity such as the following:

delta 1 cis or trans tetrahydrocannabinol, and their optical isomers

delta 6 cis or trans tetrahydrocannabinol, and their optical isomers

delta 3, 4 cis or trans tetrahydrocannabinol, and its optical isomers
(since nomenclature of these substances is not internationally
standardized, compounds of these structures, regardless of numerical
designation of atomic positions covered). Any Federal Food and Drug
Administration approved product containing tetrahydrocannabinol shall
not be considered a synthetic tetrahydrocannabinol.

(21) Ethylamine analog of phencyclidine. Some trade or other names:
N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine,
N-(1-phenylcyclohexyl) ethylamine cyclohexamine, PCE.

(22) Pyrrolidine analog of phencyclidine. Some trade or other names
1-(1-phenylcyclohexyl)-pyrrolidine; PCPy, PHP.

(23) Thiophene analog of phencyclidine. Some trade or other names:
1-{1-(2-thienyl)-cyclohexyl}-piperidine, 2-thienylanalog of
phencyclidine, TPCP, TCP.

(24) 3,4-methylenedioxymethamphetamine (MDMA).

(25) 3,4-methylendioxy-N-ethylamphetamine (also known as
N-ethyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA,
MDE, MDEA.

(26) N-hydroxy-3,4-methylenedioxyamphetamine (also known as
N-hydroxy-alpha-methyl-3,4 (methylenedioxy) phenethylamine, and
N-hydroxy MDA.

(27) 1-{1- (2-thienyl) cyclohexyl} pyrrolidine. Some other names:
TCPY.

(28) Alpha-ethyltryptamine. Some trade or other names: etryptamine;
Monase; Alpha-ethyl-1H-indole-3-ethanamine; 3- (2-aminobutyl) indole;
Alpha-ET or AET.

(29) 2,5-dimethoxy-4-ethylamphetamine. Some trade or other names:
DOET.

(30) 4-Bromo-2,5-dimethoxyphenethylamine. Some trade or other names:
2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB;
2C-B, Nexus.

(31) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its
optical isomers, salts and salts of isomers.

(33) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,
also known as 25I-NBOMe; 2C-I-NBOMe; 25I; or Cimbi-5.

(34) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,
also known as 25 CNBOMe; 2C-C-NBOMe; 25C; or Cimbi-82.

(35) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,
also known as, 25 BNBOMe; 2C-B-NBOMe; Cimbi-36.

(36) 5-methoxy-N,N-dimethyltryptamine.

(37) Alpha-methyltryptamine. Some trade or other names: AMT.

(38) 5-methoxy-N,N-diisopropyltryptamine. Some trade or other names:
5-MeO-DIPT.

(e) Depressants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a depressant
effect on the central nervous system, including its salts, isomers, and
salts of isomers whenever the existence of such salts, isomers, and
salts of isomers is possible within the specific chemical designation:

(1) Mecloqualone.

(2) Methaqualone.

(3) Phencyclidine.

(4) Gamma hydroxybutyric acid, and salt, hydroxybutyric compound,
derivative or preparation of gamma hydroxybutyric acid, including any
isomers, esters and ethers and salts of isomers, esters and ethers of
gamma hydroxybutyric acid, except gamma-butyrolactone, whenever the
existence of such isomers, esters and ethers and salts is possible
within the specific chemical.

(5) Gamma-butyrolactone, including butyrolactone; butyrolactone gamma;
4-butyrolactone; 2(3H)-furanone dihydro; dihydro-2(3H)-furanone;
tetrahydro-2-furanone; 1,2-butanolide; 1,4-butanolide; 4-butanolide;
gamma-hydroxybutyric acid lactone; 3-hydroxybutyric acid lactone and
4-hydroxybutanoic acid lactone with Chemical Abstract Service number
(96-48-0) when any such substance is intended for human consumption.

(6) 1,4 butanediol, including butanediol; butane-1,4-diol;
1,4-butylene glyco; butylene glycol; 1,4-dihydroxybutane;
1,4-tetramethylene glycol; tetramethylene glycol; tetramethylene
Abstract Service number (110-63-4) when any such substance is intended
for human consumption.

(f) Stimulants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a stimulant
effect on the central nervous system, including its salts, isomers, and
salts of isomers:

(1) Fenethylline.

(2) N-ethylamphetamine.

(3) (+ -)cis-4-methylaminorex ((+ -)cis-4,5-dihydro-4-methyl -5-phenyl
-2-oxazolamine).

(4) N,N-dimethylamphetamine (also known as N,N-alpha-
trimethyl-benzeneethanamine; N,N-alpha- trimethylphenethylamine).

(5) Methcathinone (some other names: 2-(methylamino) - propiophenone;
alpha-(methylamino) propiophenone; 2-(methylamino) -1-phenylpropan-
1-one; alpha-N- methylaminopropiophenone; monomethylpropion; ephedrone,
N-methylcathinone, methylcathinone; AL-464; AL-422; AL-463 and UR1432),
its salts, optical isomers and salts of optical isomers.

(6) Aminorex. Some other names: aminoxaphen; 2-amino-5-phenyl
-2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine.

(7) Cathinone. Some trade or other names:
2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone,
2-aminopropiophenone, and norephedrone.

(8) N-benzylpiperazine (some other names: BZP; 1-benzylpiperazine),
its optical isomers, salts and salts of isomers.

(9) 4-methyl-N-methylcathinone or 4-Methylmethcathinone, also known as
Mephedrone.

(10) 3,4-methylenedioxypyrovalerone or Methylenedioxypyrovalerone,
also known as MDPV.

(11) 3,4-methylenedioxy-N-methylcathinone (some other names:
methylone).

(12) 4-Methoxymethcathinone.

(13) 3-Fluoromethcathinone.

(14) 4-Fluoromethcathinone.

(15) Ethylpropion (Ethcathinone).

(16) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).

(17) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).

(18) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).

(19) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).

(20) 2-{4-(Ethylthio)-2,5-dimethoxyphenyl}ethanamine (2C-T-2).

(21) 2-{4-(Isopropylthio)-2,5-dimethoxyphenyl}ethanamine (2C-T-4).

(22) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).

(23) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).

(24) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).

(g) Synthetic cannabinoids. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture, or
preparation, which contains any quantity of the following synthetic
cannabinoid substances, or which contains any of its salts, isomers, and
salts of isomers whenever the existence of such salts, isomers, and
salts of isomers is possible within the specific chemical designation
(for purposes of this paragraph only, the term "isomer" includes the
optical, position and geometric isomers):

(1) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)
methanone. Some trade or other names: UR-144.

(2) {1-(5-fluro-pentyl)-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)
methanone. Some trade names or other names: 5-fluoro-UR-144, XLR11.

(3) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide. Some trade or
other names: APINACA, AKB48.

(4) quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate. Some trade or
other names: PB-22; QUPIC.

(5) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. Some
trade or other names: 5-fluoro-PB-22; 5F-PB-22.

(6) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazo-
le-3-carboxamide. Some trade or other names: AB-FUBINACA.

(7) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide. Some trade or other names: ADB-PINACA.

(8) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide. Some trade or other names: AB-CHMINACA.

(9) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide. Some trade or other names: AB-PINACA.

(10) {1-(5-fluoropentyl)-1H-indazol-3-yl}(naphthalen-1-y1)methanone.
Some trade or other names: THJ-2201.

(h) (1) Cannabimimetic agents. Unless specifically exempted or unless
listed in another schedule, any material, compound, mixture, or
preparation that is not approved by the federal food and drug
administration (FDA) which contains any quantity of cannabimimetic
agents, or which contains their salts, isomers, and salts of isomers
whenever the existence of such salts, isomers, and salts of isomers is
possible within the specific chemical designation.

(2) As used in this subdivision, the term "cannabimimetic agents"
means any substance that is a cannabinoid receptor type 1 (CB1 receptor)
agonist as demonstrated by binding studies and functional assays within
any of the following structural classes:

(i) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position
of the phenolic ring by alkyl or alkenyl, whether or not substituted on
the cyclohexyl ring to any extent.

(ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by
substitution at the nitrogen atom of the indole ring, whether or not
further substituted on the indole ring to any extent, whether or not
substituted on the naphthoyl or naphthyl ring to any extent.

(iii) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of
the pyrrole ring, whether or not further substituted in the pyrrole ring
to any extent, whether or not substituted on the naphthoyl ring to any
extent.

(iv) 1-(1-naphthylmethylene)indene by substitution of the 3-position
of the indene ring, whether or not further substituted in the indene
ring to any extent, whether or not substituted on the naphthyl ring to
any extent.

(v) 3-phenylacetylindole or 3-benzoylindole by substitution at the
nitrogen atom of the indole ring, whether or not further substituted in
the indole ring to any extent, whether or not substituted on the phenyl
ring to any extent.

(3) Such term includes:

(i) 5-(1,1-dimethylheptyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol
(CP-47,497);

(ii) 5-(1,1-dimethyloctyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol
(cannabicyclohexanol or CP-47,497 C8-homolog);

(iii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);

(iv) 1-butyl-3-(1-naphthoyl)indole (JWH-073);

(v) 1-hexyl-3-(1-naphthoyl)indole (JWH-019);

(vi) 1-{2-(4-morpholinyl)ethyl}-3-(1-naphthoyl)indole (JWH-200);

(vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);

(viii) 1-pentyl-3-{1-(4-methoxynaphthoyl)}indole (JWH-081);

(ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);

(x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);

(xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);

(xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);

(xiii) 1-pentyl-3-{(4-methoxy)-benzoyl}indole (SR-19 and RCS-4);

(xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and
RCS-8); and

(xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).

Schedule II. (a) Schedule II shall consist of the drugs and other
substances, by whatever official name, common or usual name, chemical
name, or brand name designated, listed in this section.

(b) Substances, vegetable origin or chemical synthesis. Unless
specifically excepted or unless listed in another schedule, any of the
following substances whether produced directly or indirectly by
extraction from substances of vegetable origin, or independently by
means of chemical synthesis, or by a combination of extraction and
chemical synthesis:

(1) Opium and opiate, and any salt, compound, derivative, or
preparation of opium or opiate, excluding apomorphine, dextrorphan,
nalbuphine, nalmefene, naloxone, and naltrexone, and their respective
salts, but including the following:

1. Raw opium.

2. Opium extracts.

3. Opium fluid.

4. Powdered opium.

5. Granulated opium.

6. Tincture of opium.

7. Codeine.

8. Ethylmorphine.

9. Etorphine hydrochloride.

10. Hydrocodone (also known as dihydrocodeinone).

11. Hydromorphone.

12. Metopon.

13. Morphine.

14. Oxycodone.

15. Oxymorphone.

16. Thebaine.

17. Dihydroetorphine.

18. Oripavine.

(2) Any salt, compound, derivative, or preparation thereof which is
chemically equivalent or identical with any of the substances referred
to in this section, except that these substances shall not include the
isoquinoline alkaloids of opium.

(3) Opium poppy and poppy straw.

(4) Coca leaves and any salt, compound, derivative, or preparation of
coca leaves, and any salt, compound, derivative, or preparation thereof
which is chemically equivalent or identical with any of these substances
including cocaine and ecgonine, their salts, isomers, and salts of
isomers, except that the substances shall not include: (A) decocainized
coca leaves or extraction of coca leaves, which extractions do not
contain cocaine or ecgonine; or (B) {123I} ioflupane.

(5) Concentrate of poppy straw (the crude extract of poppy straw in
either liquid, solid or powder form which contains the phenanthrene
alkaloids of the opium poppy).

(b-1) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation containing any
of the following, or their salts calculated as the free anhydrous base
or alkaloid, in limited quantities as set forth below:

(1) Not more than three hundred milligrams of dihydrocodeinone
(hydrocodone) per one hundred milliliters or not more than fifteen
milligrams per dosage unit, with a fourfold or greater quantity of an
isoquinoline alkaloid of opium.

(2) Not more than three hundred milligrams of dihydrocodeinone
(hydrocodone) per one hundred milliliters or not more than fifteen
milligrams per dosage unit, with one or more active nonnarcotic
ingredients in recognized therapeutic amounts.

(c) Opiates. Unless specifically excepted or unless in another
schedule any of the following opiates, including its isomers, esters,
ethers, salts and salts of isomers, esters and ethers whenever the
existence of such isomers, esters, ethers, and salts is possible within
the specific chemical designation, dextrorphan and levopropoxyphene
excepted:

(1) Alfentanil.

(2) Alphaprodine.

(3) Anileridine.

(4) Bezitramide.

(5) Bulk dextropropoxyphene (non-dosage forms).

(6) Carfentanil.

(7) Dihydrocodeine.

(8) Diphenoxylate.

(9) Fentanyl.

(10) Isomethadone.

(11) Levo-alphacetylmethadol (also known as levo-alpha-acetylmethadol,
levomethadylacetate or LAAM).

(12) Levomethorphan.

(13) Levorphanol.

(14) Metazocine.

(15) Methadone.

(16) Methadone-intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl
butane.

(17) Moramide-intermediate, 2-methyl-3-morpholino-1,
1--diphenylpropane--carboxylic acid.

(18) Pethidine (meperidine).

(19) Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine.

(20) Pethidine-intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate.

(21) Pethidine-intermediate-C, 1--methyl--4-- phenylpiperidine--4--
carboxylic acid.

(22) Phenazocine.

(23) Piminodine.

(24) Racemethorphan.

(25) Racemorphan.

(26) Sufentanil.

(27) Remifentanil.

(28) Tapentadol.

(29) Thiafentanil.

(d) Stimulants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a stimulant
effect on the central nervous system, including its salts, isomers, and
salts of isomers:

(1) Amphetamine.

(2) Methamphetamine.

(3) Phenmetrazine.

(4) Methylphenidate.

(5) Lisdexamfetamine.

(e) Depressants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a depressant
effect on the central nervous system, including its salts, isomers, and
salts of isomers whenever the existence of such salts, isomers, and
salts of isomers is possible within the specific chemical designation:

(1) Amobarbital.

(2) Glutethimide.

(3) Pentobarbital.

(4) Secobarbital.

(f) Hallucinogenic substances.

Nabilone: Another name for nabilone: (+,-)-trans
-3-(1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy-6,
6-dimethyl-9H-dibenzo{b,d}pyran-9-one.

(g) Immediate precursors. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture or
preparation which contains any quantity of the following substances:

(1) Immediate precursor to amphetamine and methamphetamine:

(i) Phenylacetone Some trade or other names: pheny1-2-propanone; P2P;
benzyl methyl ketone; methyl benzyl ketone;

(2) Immediate precursors to phencyclidine (PCP):

(i) 1-phenylcyclohexylamine;

(ii) 1-piperidinocyclohexanecarbonitrile (PCC).

(3) Immediate precursor to fentanyl:

(i) 4-anilino-N-phenethyl-4-piperidine (ANPP).

(h) Anabolic steroids. Unless specifically excepted or unless listed
in another schedule, "anabolic steroid" shall mean any drug or hormonal
substance, chemically and pharmacologically related to testosterone
(other than estrogens, progestins, corticosteroids and
dehydroepiandrosterone) and includes:

(1) 3{beta}, 17-dihydroxy-5a-androstane.

(2) 3{alpha}, 17{beta}-dihydroxy-5a-androstane.

(3) 5{alpha}-androstan-3,17-dione.

(4) 1-androstenediol (3{beta},17{beta}-dihydroxy-5{alpha}-androst-1-
ene).

(5) 1-androstenediol (3{alpha},17{beta}-dihydroxy-5{alpha}-androst-1-
ene).

(6) 4-androstenediol (3{beta}, 17{beta}-dihydroxy-androst-4-ene).

(7) 5-androstenediol (3{beta}, 17{beta}-dihydroxy-androst-5-ene).

(8) 1-androstenedione ({5{alpha}}-androst-1-en-3,17-dione).

(9) 4-androstenedione (androst-4-en-3,17-dione).

(10) 5-androstenedione (androst-5-en-3,17-dione).

(11) Bolasterone (7{alpha},17{alpha}-dimethyl-17{beta}-hydroxyandrost-
4-en-3-one).

(12) Boldenone (17{beta}-hydroxyandrost-1, 4,-diene-3-one).

(13) Boldione (androsta-1,4-diene-3,17-dione).

(14) Calusterone (7{beta}, 17{alpha}-dimethyl-17{beta}-hydroxyandrost-
4-en-3-one).

(15) Clostebol (4-chloro-17{beta}-hydroxyandrost-4-en-3-one).

(16) Dehydrochloromethyltestosterone (4-chloro-17{beta}-hydroxy-17
{alpha}-methyl-androst-1, 4-dien-3-one).

(17) {Delta} 1-dihydrotestosterone (a.k.a. '1-testosterone') (17
{beta}-hydroxy-5{alpha}-androst-1-en-3-one).

(18) 4-dihydrotestosterone (17{beta}-hydroxy-androstan-3-one).

(19) Drostanolone (17{beta}-hydroxy-2{alpha}-methyl-5{alpha}
-androstan-3-one).

(20) Ethylestrenol (17{alpha}-ethyl-17{beta}-hydroxyestr- 4-ene).

(21) Fluoxymesterone (9-fluoro-17{alpha}-methyl-11{beta}, 17 {beta}-
dihydroxyandrost-4-en-3-one).

(22) Formebolone (2-formyl-17{alpha}-methyl-11{alpha},
17{beta}-dihydroxyandrost-1, 4-dien-3-one).

(23) Furazabol (17{alpha}-methyl-17{beta}-hydroxyandrostano
{2, 3-c}-furazan).

(24) 13{beta}-ethyl-17{beta}-hyroxygon-4-en-3-one.

(25) 4-hydroxytestosterone (4, 17{beta}-dihydroxy-androst-4-en-3-one).

(26) 4-hydroxy-19-nortestosterone
(4,17{beta}-dihydroxy-estr-4-en-3-one).

(27) desoxymethyltestosterone
(17{alpha}-methyl-5{alpha}-androst-2-en-17{beta}-ol) (a.k.a., madol).

(28) Mestanolone (17{alpha}-methyl-17{beta}-hydroxy-
5-androstan-3-one).

(29) Mesterolone (1{alpha} methyl-17{beta}-hydroxy-
{5{alpha}}-androstan-3-one).

(30) Methandienone (17{alpha}-methyl-17{beta}-hydroxyandrost-1,
4-dien-3-one).

(31) Methandriol (17{alpha}-methyl-3{beta},
17{beta}-dihydroxyandrost-5-ene).

(32) Methenolone (1-methyl-17{beta}-hydroxy-5{alpha}-androst-
1-en-3-one).

(33) 17{alpha}-methyl-3{beta},17{beta}-dihydroxy-5a-androstane.

(34) 17{alpha}-methyl-3{alpha}, 17{beta}-dihydroxy- 5a-androstane.

(35) 17{alpha}-methyl-3{beta}, 17{beta}-dihydroxyandrost-4-ene.

(36) 17{alpha}-methyl-4-hydroxynandrolone (17{alpha}-methyl-4-
hydroxy-17{beta}-hydroxyestr-4-en-3-one).

(37) Methyldienolone (17{alpha}-methyl-17{beta}-hydroxyestra-
4,9(10)-dien-3-one).

(38) Methyltrienolone (17{alpha}-methyl-17{beta}-hydroxyestra-4,
9-11-trien-3-one).

(39) Methyltestosterone (17{alpha}-methyl-17{beta}-hydroxyandrost-
4-en-3-one).

(40) Mibolerone (7{alpha},17{alpha}-dimethyl-17{beta}-hydroxyestr-
4-en-3-one).

(41) 17{alpha}-methyl-{Delta} 1-dihydrotestosterone
(17b{beta}-hydroxy-17{alpha}-methyl-5{alpha}-androst-1-en-3-one)
(a.k.a. '17-{alpha}-methyl-1-testosterone').

(42) Nandrolone(17{beta}-hydroxyestr-4-en-3-one).

(43) 19-nor-4-androstenediol (3{beta},17{beta}-dihydroxyestr -4-ene).

(44) 19-nor-4-androstenediol (3{alpha},17{beta}-dihydroxyestr-4-ene).

(45) 19-nor-5-androstenediol (3{beta},17{beta}-dihydroxyestr -5-ene).

(46) 19-nor-5-androstenediol (3{alpha},17{beta}-dihydroxyestr-5-ene).

(47) 19-nor-4,9(10)-androstadienedione
(estra-4,9(10)-diene-3,17-dione).

(48) 19-nor-4-androstenedione (estr-4-en-3,17-dione).

(49) 19-nor-5-androstenedione (estr-5-en-3,17-dione).

(50) Norbolethone (13{beta}, 17{alpha}-diethyl-17{beta}
-hydroxygon-4-en-3-one).

(51) Norclostebol (4-chloro-17{beta}-hydroxyestr-4-en-3-one).

(52) Norethandrolone (17{alpha}-ethyl-17{beta}-hydroxyestr-
4-en-3-one).

(53) Normethandrolone (17{alpha}-methyl-17{beta}
-hydroxyestr-4-en-3-one).

(54) Oxandrolone (17{alpha}-methyl-17{beta}-hydroxy-2-oxa-
{5{alpha}}-androstan-3-one).

(55) Oxymesterone (17{alpha}-methyl-4, 17{beta}-dihydroxy
androst-4-en-3-one).

(56) Oxymetholone (17 {alpha}-methyl-2-hydroxymethylene-17
{beta}-hydroxy-{5{alpha}}- androstan-3-one).

(57) Stanozolol (17{alpha}-methyl-17{beta}-hydroxy-{5{alpha}}-
androst-2-eno{3, 2-c}-pyrazole).

(58) Stenbolone (17{beta}-hydroxy-2-methyl-{5{alpha}}-androst-
1-en-3-one).

(59) Testolactone (13-hydroxy-3-oxo-13, 17-secoandrosta-1,
4-dien-17-oic acid lactone).

(60) Testosterone (17{beta}-hydroxyandrost-4-en-3-one).

(61) Tetrahydrogestrinone (13{beta}, 17{alpha}-diethyl
-17{beta}-hydroxygon-4, 9, 11-trien-3-one).

(62) Trenbolone (17{beta}-hydroxyestr-4, 9, 11-trien-3-one).

(63) Any salt, ester or ether of a drug or substance described or
listed in this subdivision.

(i) Subdivision (h) of this section shall not include any substance
containing anabolic steroids expressly intended for administration
through implants to cattle or other nonhuman species and that are
approved by the federal food and drug administration solely for such
use. Any individual who knowingly and willfully administers to himself
or another person, prescribes, dispenses or distributes such substances
for other than implantation to cattle or nonhuman species shall be
subject to the same penalties as a practitioner who violates the
provisions of this section or any other penalties prescribed by law.

Schedule III. (a) Schedule III shall consist of the drugs and other
substances, by whatever official name, common or usual name, chemical
name, or brand name designated, listed in this section.

(b) Stimulants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a stimulant
effect on the central nervous system, including its salts, isomers
(whether optical, position, or geometric), and salts of such isomers
whenever the existence of such salts, isomers, and salts of isomers is
possible within the specific chemical designation:

(1) Those compounds, mixtures, or preparations in dosage unit form
containing any stimulant substances listed in schedule II which
compounds, mixtures, or preparations were listed on August twenty-five,
nineteen hundred seventy-one, as excepted compounds under title
twenty-one, section 308.32 of the code of federal regulations and any
other drug of the quantitive composition shown in that list for those
drugs or which is the same except that it contains a lesser quantity of
controlled substances.

(2) Benzphetamine.

(3) Chlorphentermine.

(4) Clortermine.

(6) Phendimetrazine.

(c) Depressants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a depressant
effect on the central nervous system, including its salts, isomers, and
salts of isomers:

(1) Any compound, mixture or preparation containing:

(i) Amobarbital;

(ii) Secobarbital;

(iii) Pentobarbital;
or any salt thereof and one or more other active medicinal ingredients
which are not listed in any schedule.

(2) Any suppository dosage form containing:

(i) Amobarbital;

(ii) Secobarbital;

(iii) Pentobarbital;
or any salt of any of these drugs and approved by the federal food and
drug administration for marketing only as a suppository.

(3) Any substance which contains any quantity of a derivative of
barbituric acid or any salt thereof.

(4) Chlorhexadol.

(5) Lysergic acid.

(6) Lysergic acid amide.

(7) Methyprylon.

(8) Sulfondiethylmethane.

(9) Sulfonethylmethane.

(10) Sulfonmethane.

(11) Tiletamine and zolazepam or any salt thereof. Some trade or other
names for a tiletamine-zolazepam combination product: Telazol. Some
trade or other names for tiletamine: 2-(ethylamino) -2-(2-thienyl)
-cyclohexanone. Some trade or other names for zolazepam:
4-(2-fluorophenyl) -6,8-dihydro -1, 3, 8i-trimethylpyrazolo-{3,4-e}
{1,4} -diazepin-7(1H)-one, flupyrazapon.

(12) Gamma hydroxybutyric acid, and salt, hydroxybutyric compound,
derivative or preparation of gamma hydroxybutyric acid, including any
isomers, esters and ethers and salts of isomers, esters and ethers of
gamma hydroxybutyric acid, contained in a drug product for which an
application has been approved under section 505 of the federal food,
drug and cosmetic act.

(13) Ketamine, its salts, isomers and salts of isomers (some
other names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)-
cyclohexanone).

(14) Embutramide.

(d) Nalorphine.

(e) Narcotic drugs. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
containing any of the following narcotic drugs, or their salts
calculated as the free anhydrous base or alkaloid, in limited quantities
as set forth below:

(1) Not more than 1.8 grams of codeine per one hundred milliliters or
not more than ninety milligrams per dosage unit, with an equal or
greater quantity of an isoquinoline alkaloid of opium.

(2) Not more than 1.8 grams of codeine per one hundred milliliters or
not more than ninety milligrams per dosage unit, with one or more
active, nonnarcotic ingredients in recognized therapeutic amounts.

(3) Not more than 1.8 grams of dihydrocodeine per one hundred
milliliters or not more than ninety milligrams per dosage unit, with one
or more active nonnarcotic ingredients in recognized therapeutic
amounts.

(4) Not more than three hundred milligrams of ethylmorphine per one
hundred milliliters or not more than fifteen milligrams per dosage unit,
with one or more active, nonnarcotic ingredients in recognized
therapeutic amounts.

(5) Not more than five hundred milligrams of opium per one hundred
milliliters or per one hundred grams or not more than twenty-five
milligrams per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts.

(6) Not more than fifty milligrams of morphine per one hundred
milliliters or per one hundred grams, with one or more active,
nonnarcotic ingredients in recognized therapeutic amounts.

(7) Buprenorphine in any quantities.

(f) Dronabinol (synthetic) in sesame oil and encapsulated in a soft
gelatin capsule in a U.S. Food and Drug Administration approved product.

Some other names for dronabinol include: (6aR-trans)-6a, 7, 8,
10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo{b,d} pyran-1-o1, or
(-)-delta-9-(trans) - tetrahydrocannabinol.

(g) Chorionic gonadotropin. (1) Unless specifically excepted or unless
listed in another schedule any material, compound, mixture, or
preparation which contains any amount of chorionic gonadotropin.

(2) Paragraph one of this subdivision shall not include any substance
containing chorionic gonadotropin expressly intended for administration
through implants or injection to cattle or other nonhuman species and
that are approved by the federal food and drug administration solely for
such use. Any individual who knowingly and willfully administers to
himself or another person, prescribes, dispenses or distributes such
substances for other than implantation or injection to cattle or
nonhuman species shall be subject to the same penalties as a
practitioner who violates the provisions of this section or any other
penalties prescribed by law.

Schedule IV. (a) Schedule IV shall consist of the drugs and other
substances, by whatever official name, common or usual name, chemical
name, or brand name designated, listed in this section.

(b) Narcotic drugs. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
containing any of the following narcotic drugs, or their salts
calculated as the free anhydrous base or alkaloid, in limited quantities
as set forth below:

(1) Not more than one milligram of difenoxin and not less than
twenty-five micrograms of atropine sulfate per dosage unit.

(2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-
methyl-2-propionoxybutane).

(c) Depressants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances, including its salts,
isomers, and salts of isomers whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific chemical
designation:

(1) Alprazolam.

(2) Barbital.

(3) Bromazepam.

(4) Camazepam.

(5) Chloral betaine.

(6) Chloral hydrate.

(7) Chlordiazepoxide.

(8) Clobazam.

(9) Clonazepam.

(10) Clorazepate.

(11) Clotiazepam.

(12) Cloxazolam.

(13) Delorazepam.

(14) Diazepam.

(15) Estazolam.

(16) Ethchlorvynol.

(17) Ethinamate.

(18) Ethyl Loflazepate.

(19) Fludiazepam.

(20) Flunitrazepam.

(21) Flurazepam.

(22) Halazepam.

(23) Haloxazolam.

(24) Ketazolam.

(25) Loprazolam.

(26) Lorazepam.

(27) Lormetazepam.

(28) Mebutamate.

(29) Medazepam.

(30) Meprobamate.

(31) Methohexital.

(32) Methylphenobarbital (mephobarbital).

(33) Nimetazepam.

(34) Nitrazepam.

(35) Nordiazepam.

(36) Oxazepam.

(37) Oxazolam.

(38) Paraldehyde.

(39) Petrichoral.

(40) Phenobarbital.

(41) Pinazepam.

(42) Prazepam.

(43) Temazepam.

(44) Tetrazepam.

(45) Triazolam.

(46) Midazolam.

(47) Quazepam.

(48) Zolpidem.

(49) Dichloralphenazone.

(50) Zaleplon.

(51) Zopiclone (eszopiclone).

(52) Fospropofol.

(53) Carisoprodol.

* (d) Fenfluramine. Any material, compound, mixture, or preparation
which contains any quantity of the following substances, including its
salts, isomers (whether optical, position, or geometric), and salts of
such isomers, whenever the existence of such salts, isomers and salts of
isomers is possible:

(1) Fenfluramine.

* NB Repealed upon the removal of fenfluramine and its salts and
isomers from Schedule IV of the federal Controlled Substances Act

(e) Stimulants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a stimulant
effect on the central nervous system, including its salts, isomers, and
salts of such isomers:

(1) Cathine ((+) - norpseudoephedrine).

(2) Diethylpropion.

(3) Fencamfamin.

(4) Fenproporex.

(5) Mazindol.

(6) Mefenorex.

(7) Pemoline (including organometallic complexes and chelates
thereof).

(8) Phentermine.

(9) Pipradrol.

(10) SPA((-))-1-dimethylamino-1, 2-diphenylethane).

(11) Modafinil.

(12) Sibutramine.

(f) Other substances. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture or preparation which
contains any quantity of the following substances, including its salts:

(1) Pentazocine.

(2) Butorphanol (including its optical isomers).

(3) Tramadol in any quantities.

Schedule V. (a) Schedule V shall consist of the drugs and other
substances, by whatever official name, common or usual name, chemical
name, or brand name designated, listed in this section.

(b) Narcotic drugs containing nonnarcotic active medicinal
ingredients. Any compound, mixture, or preparation containing any of
the following narcotic drugs, or their salts calculated as the free
anhydrous base or alkaloid, in limited quantities as set forth below,
which shall include one or more nonnarcotic active medicinal ingredients
in sufficient proportion to confer upon the compound, mixture, or
preparation valuable medicinal qualities other than those possessed by
narcotic drugs alone:

(1) Not more than two hundred milligrams of codeine per one hundred
milliliters or per one hundred grams.

(2) Not more than one hundred milligrams of dihydrocodeine per one
hundred milliliters or per one hundred grams.

(3) Not more than one hundred milligrams of ethylmorphine per one
hundred milliliters or per one hundred grams.

(4) Not more than 2.5 milligrams of diphenoxylate and not less than
twenty-five micrograms of atropine sulfate per dosage unit.

(5) Not more than one hundred milligrams of opium per one hundred
milliliters or per one hundred grams.

(6) Not more than 0.5 milligram of difenoxin and not less than
twenty-five micrograms of atropine sulfate per dosage unit.

(c) Stimulants. Unless specifically exempted or excluded or unless
listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances
having a stimulant effect on the central nervous system, including its
salts, isomers and salts of isomers:

(1) Pyrovalerone.

(d) Depressants. Unless specifically exempted or excluded or unless
listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances
having a depressant effect on the central nervous system, including its
salts, isomers, and salts of isomers:

(1) Ezogabine {N-{2-amino-4-(4-fluorobenzylamino)-phenyl}-carbamic
acid ethyl ester}.

(2) Lacosamide {(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide}.

(3) Pregabalin {(S)-3-(aminomethyl)-5-methylhexanoic acid }.